HIV-Related Refractory Hodgkin Lymphoma: A Case Report of Complete Response to Nivolumab

We present a case of a patient with well-controlled human immunodeficiency virus (HIV) infection and refractory classical Hodgkin lymphoma (HL) treated with nivolumab as fifth-line treatment, who achieved complete response (CR) by positron emission tomography –computed tomography (PET/CT). To our knowledge, this is the second case report of a patient exhibiting nivolumab’s response, and first reported CR in the setting of HIV-associated HL (HIV-HL).

Source: Clinical Lymphoma, Myeloma and Leukemia - January 3, 2018 Category: Hematology Authors: Elaine Chang, Gustavo Rivero, Niraj R. Patel, Elizabeth Y. Chiao, Syeling Lai, Kelash Bajaj, John E. Mbue, Sarvari V. Yellapragada Tags: Case Report Source Type: research